Universität zu Köln

Baertsch, Marc-Andrea, Mai, Elias K., Hielscher, Thomas, Bertsch, Uta, Salwender, Hans J., Munder, Markus, Fuhrmann, Stephan ORCID: 0000-0002-7785-2565, Duehrsen, Ulrich, Brossart, Peter, Neben, Kai, Schlenzka, Jana, Kunz, Christina, Raab, Marc S., Hillengass, Jens, Jauch, Anna, Seckinger, Anja, Hose, Dirk, Luntz, Steffen, Sonneveld, Pieter, Lokhorst, Henk, Martin, Hans, Goerner, Martin, Hoffmann, Martin, Lindemann, Hans-Walter, Bernhard, Helga, Blau, Igor W., Scheid, Christof, Besemer, Britta, Weisel, Katja C., Haenel, Mathias, Duerig, Jan and Goldschmidt, Hartmut (2021). Lenalidomide versus bortezomib maintenance after frontline autologous stem cell transplantation for multiple myeloma. Blood Cancer J., 11 (1). LONDON: SPRINGERNATURE. ISSN 2044-5385

Borchmann, Peter, Haverkamp, Heinz, Lohri, Andreas, Kreissl, Stefanie, Greil, Richard, Markova, Jana, Feuring-Buske, Michaela, Meissner, Julia, Duehrsen, Ulrich, Engel, Nicole, Keller, Ulrich, Maschmeyer, Georg, Dietlein, Markus, Kobe, Carsten, Fuchs, Michael, Diehl, Volker and Engert, Andreas (2014). Addition of Rituximab to BEACOPP(escalated) to Improve the Outcome of Early Interim PET Positive Advanced Stage Hodgkin Lymphoma Patients: Second Planned Interim Analysis of the HD18 Study. Blood, 124 (21). WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020

Borchmann, Peter, Haverkamp, Heinz ORCID: 0000-0001-6895-4132, Lohri, Andreas, Mey, Ulrich, Kreissl, Stefanie, Greil, Richard, Markova, Jana, Feuring-Buske, Michaela, Meissner, Julia, Duehrsen, Ulrich, Ostermann, Helmut, Keller, Ulrich, Maschmeyer, Georg, Kuhnert, Georg, Dietlein, Markus, Kobe, Carsten, Eich, Hans, Baues, Christian, Stein, Harald, Fuchs, Michael, Diehl, Volker and Engert, Andreas (2017). Progression-free survival of early interim PET-positive patients with advanced stage Hodgkin's lymphoma treated with BEACOPP(escalated) alone or in combination with rituximab (HD18): an open-label, international, randomised phase 3 study by the German Hodgkin Study Group. Lancet Oncol., 18 (4). S. 454 - 464. NEW YORK: ELSEVIER SCIENCE INC. ISSN 1474-5488

Fuchs, Michael, Goergen, Helen, Kobe, Carsten, Kuhnert, Georg, Lohri, Andreas, Greil, Richard, Sasse, Stephanie, Topp, Max S., Schaefer, Erhardt, Hertenstein, Bernd, Soekler, Martin, Vogelhuber, Martin, Zijlstra, Josee M., Keller, Ulrich Bernd, Krause, Stefan W., Wilhelm, Martin, Maschmeyer, Georg, Thiemer, Julia, Duehrsen, Ulrich, Meissner, Julia, Viardot, Andreas, Eich, Hans, Baues, Christian, Diehl, Volker, Rosenwald, Andreas, von Tresckow, Bastian, Dietlein, Markus, Borchmann, Peter and Engert, Andreas (2019). Positron Emission Tomography-Guided Treatment in Early-Stage Favorable Hodgkin Lymphoma: Final Results of the International, Randomized Phase III HD16 Trial by the German Hodgkin Study Group. J. Clin. Oncol., 37 (31). S. 2835 - 2847. ALEXANDRIA: AMER SOC CLINICAL ONCOLOGY. ISSN 1527-7755

Hermine, Olivier ORCID: 0000-0003-2574-3874, Hoster, Eva ORCID: 0000-0002-0749-1389, Walewski, Jan ORCID: 0000-0003-4247-2674, Bosly, Andre, Stilgenbauer, Stephan, Thieblemont, Catherine ORCID: 0000-0002-9941-2448, Szymczyk, Michal, Bouabdallah, Reda, Kneba, Michael, Hallek, Michael, Salles, Gilles ORCID: 0000-0002-9541-8666, Feugier, Pierre, Ribrag, Vincent, Birkmann, Josef, Forstpointner, Roswitha, Haioun, Corinne, Haenel, Mathias, Casasnovas, Rene Olivier, Finke, Juergen, Peter, Norma, Bouabdallah, Kamal, Sebban, Catherine, Fischer, Thomas, Duehrsen, Ulrich, Metzner, Bernd, Maschmeyer, Georg, Kanz, Lothar, Schmidt, Christian, Delarue, Richard, Brousse, Nicole, Klapper, Wolfram, Macintyre, Elizabeth, Delfau-Larue, Marie-Helene, Pott, Christiane, Hiddemann, Wolfgang, Unterhalt, Michael and Dreyling, Martin (2016). Addition of high-dose cytarabine to immunochemotherapy before autologous stem-cell transplantation in patients aged 65 years or younger with mantle cell lymphoma (MCL Younger): a randomised, open-label, phase 3 trial of the European Mantle Cell Lymphoma Network. Lancet, 388 (10044). S. 565 - 576. NEW YORK: ELSEVIER SCIENCE INC. ISSN 1474-547X

Hoster, Eva, Unterhalt, Michael, Pfreundschuh, Michael, Hallek, Michael, Forstpointner, Roswitha, Metzner, Bernd, Einsele, Hermann, Krauter, Juergen, Duehrsen, Ulrich, Ludwig, Wolf-Dieter, Birkmann, Josef, Peter, Norma, Klapper, Wolfram, Dreyling, Martin H. and Hiddemann, Wolfgang (2014). The Addition of Rituximab to CHOP Improves Failure-Free and Overall Survival of Mantle-Cell Lymphoma Patients - a Pooled Trials Analysis of the German Low-Grade Lymphoma Study Group (GLSG). Blood, 124 (21). WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020

Jenke, Petra, Eichhorst, Barbara, Busch, Raymonde, Anheier, Nadine, Duehrsen, Ulrich, Duerig, Jan, Dreyling, Martin H., Bergmann, Manuela, Goebeler, Maria Elisabeth, Hurts, Hans Juergen, Stauch, Martina Beate, Stilgenbauer, Stephan, Doehner, Hartmut, Fink, Anna-Maria, Fischer, Kirsten, Wendtner, Clemens-Martin and Hallek, Michael (2011). Cyclophosphamide, Adriamycin, Vincristine and Prednisone Plus Rituximab (CHOP-R) in Fludarabine (F) Refractory Chronic Lymphocytic Leukemia (CLL) or CLL with Autoimmune Cytopenia (AIC) or Richter's Transformation (RT): Final Analysis of a Phase II Study of the German CLL Study Group. Blood, 118 (21). S. 1233 - 1235. WASHINGTON: AMER SOC HEMATOLOGY. ISSN 0006-4971

Kurtz, David M., Esfahani, Mohammad S., Scherer, Florian, Soo, Joanne, Jin, Michael C., Liu, Chih Long, Newman, Aaron M., Duehrsen, Ulrich, Huettmann, Andreas, Casasnovas, Olivier, Westin, Jason R., Ritgen, Matthais, Boettcher, Sebastian, Langerak, Anton W., Roschewski, Mark, Wilson, Wyndham H., Gaidano, Gianluca, Rossi, Davide, Bahlo, Jasmin, Hallek, Michael, Tibshirani, Robert, Diehn, Maximilian and Alizadeh, Ash A. (2019). Dynamic Risk Profiling Using Serial Tumor Biomarkers for Personalized Outcome Prediction. Cell, 178 (3). S. 699 - 733. CAMBRIDGE: CELL PRESS. ISSN 1097-4172

Mai, Elias K., Hielscher, Thomas, Bertsch, Uta, Schlenzka, Jana, Salwender, Hans J., Munder, Markus, Gerecke, Christian, Duehrsen, Ulrich, Brossart, Peter, Neben, Kai, Hillengass, Jens, Raab, Marc S., Merz, Maximilian, Baertsch, Marc-Andrea, Jauch, Anna, Hose, Dirk, Martin, Hans, Lindemann, Hans-Walter, Blau, Igor W., Scheid, Christof, Weisel, Katja C. and Goldschmidt, Hartmut (2019). Bortezomib-based induction therapy with high or low-dose dexamethasone in newly diagnosed, transplant-eligible multiple myeloma. Leukemia, 33 (1). S. 258 - 262. LONDON: NATURE PUBLISHING GROUP. ISSN 1476-5551

Mai, Elias Karl ORCID: 0000-0002-6226-1252, Kunz, Christina, Bertsch, Uta, Salwender, Hans-Juergen, Pfreundschuh, Michael, Duehrsen, Ulrich, Brossart, Peter, Peter, Norma, Neben, Kai, Hielscher, Thomas, Hillengass, Jens, Martin, Hans, Lindemann, Hans Walter, Scheid, Christof, Weisel, Katja C., Blau, Igor W. and Goldschmidt, Hartmut (2015). Impact of Severe Infections during Induction Therapy on Dosage, Response and Survival in Newly Diagnosed Multiple Myeloma - a Subgroup Analysis from the Randomized Phase III Trial GMMG-HD4. Blood, 126 (23). WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020

Seckinger, Anja, Salwender, Hans Juergen, Martin, Hans, Scheid, Christof, Hielscher, Thomas, Bertsch, Uta, Hummel, Manuela, Jauch, Anna, Knauf, Wolfgang, Emde, Martina, Beck, Susanne, Neben, Kai, Lokhorst, Henk M., van der Holt, Bronno, Duehrsen, Ulrich, Duerig, Jan, Lindemann, Hans-Walter, Schmidt-Wolf, Ingo, Haenel, Mathias, Lathan, Bernd, Raab, Marc S., Mueller-Tidow, Carsten, Sonneveld, Pieter, Blau, Igor Wolfgang, Hillengass, Jens, Weisel, Katja, Goldschmidt, Hartmut and Hose, Dirk (2018). Treatment Response and Long-Term Survival in Multiple Myeloma in the GMMG-HD4 Trail - Neither Profit All Molecular Entities Alike, Nor Are Remissions to Different Regimen Equal. Blood, 132. WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020

Seifert, Robert, Kersting, David ORCID: 0000-0002-8451-1830, Rischpler, Christoph, Sandach, Patrick, Ferdinandus, Justin, Fendler, Wolfgang P., Rahbar, Kambiz, Weckesser, Matthias, Umutlu, Lale, Hanoun, Christine, Huettmann, Andreas, Reinhardt, Hans Christian, von Tresckow, Bastian, Herrmann, Ken, Duehrsen, Ulrich and Schaefers, Michael . Interim FDG-PET analysis to identify patients with aggressive non-Hodgkin lymphoma who benefit from treatment intensification: a post-hoc analysis of the PETAL trial. Leukemia. LONDON: SPRINGERNATURE. ISSN 1476-5551

Sonneveld, Pieter, Salwender, Hans-Juergen, Van der Holt, Bronno, el Jarari, Laila, Bertsch, Uta, Blau, Igor W., Zweegman, Sonja, Weisel, Katja C., Vellenga, Edo, Pfreundschuh, Michael, Broijl, Annemiek, Scheid, Christof, Wittebol, Shulamiet, Bos, Gerard M. J., Stevens-Kroef, Marjan, Jauch, Anna, Potamianou, Anna, Hose, Dirk, Raymakers, Reinier, Schaafsme, Marinus, Kersten, Marie Jose, Kooy, Marinus van Marwijk, Duehrsen, Ulrich, Lindemann, Hans Walter, Brossart, Peter, Wijermans, Pierre, Lokhorst, Henk M. and Goldschmidt, Hartmut (2015). Bortezomib Induction and Maintenance in Patients with Newly Diagnosed Multiple Myeloma: Long-Term Follow-up of the HOVON-65/GMMG-HD4 Trial. Blood, 126 (23). WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020

Younes, Anas, Sehn, Laurie H., Johnson, Peter ORCID: 0000-0003-2306-4974, Zinzani, Pier Luigi, Hong, Xiaonan, Zhu, Jun, Patti, Caterina, Belada, David ORCID: 0000-0002-4981-6188, Samoilova, Olga, Suh, Cheolwon, Leppae, Sirpa, Rai, Shinya, Turgut, Mehmet, Jurczak, Wojciech ORCID: 0000-0003-1879-8084, Cheung, Matthew C., Gurion, Ronit, Yeh, Su-Peng, Lopez-Hernandez, Andres, Duehrsen, Ulrich, Thieblemont, Catherine, Chiattone, Carlos Sergio, Balasubramanian, Sriram, Carey, Jodi, Liu, Grace, Shreeve, S. Martin, Sun, Steven, Zhuang, Sen Hong, Vermeulen, Jessica, Staudt, Louis M., Wilson, Wyndham, Fisher, Richard I., Engert, Andreas, Stadtmauer, Edward A. and Wei, Lee-Jen (2019). Randomized Phase III Trial of Ibrutinib and Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone in Non-Germinal Center B-Cell Diffuse Large B-Cell Lymphoma. J. Clin. Oncol., 37 (15). S. 1285 - 1307. ALEXANDRIA: AMER SOC CLINICAL ONCOLOGY. ISSN 1527-7755